April 12, 2022
Ribonexus receives €2M in deep tech financing from Bpifrance
Ribonexus, a biotechnology start-up developing new therapies that can overcome resistance to current targeted therapies in cancer patients has received €2 million ($2.19M) in funds from the French public investment bank Bpifrance.